Diabetic nephropathy is a significant cause of chronic kidney disease and end-stage renal
failure globally. Much research has been conducted in both basic science and clinical …

Approximately 20% to 40% of patients with type 1 or type 2 diabetes mellitus develop
diabetic kidney disease. This is a clinical syndrome characterized by persistent albuminuria …

Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney
disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD …

The current view of diabetic kidney disease, based on meticulously acquired ultrastructural
morphometry and the utility of measuring plasma creatinine and urinary albumin, has been …

Chronic kidney disease (CKD) typically evolves over many years, with a long latent period
when the disease is clinically silent and therefore diagnosis, evaluation and treatment is …

Diabetic kidney disease (DKD) occurs in 25%-40% of patients with diabetes. Given the dual
problems of a significant risk of progression from DKD to end-stage renal disease (ESRD) …

Interstitial fibrosis is the common endpoint of end-stage chronic kidney disease (CKD)
leading to kidney failure. The clinical course of many renal diseases, and thereby of CKD, is …

Chronic kidney disease (CKD) is a major public health problem. The classification of CKD by
KDOQI and KDIGO and the routine eGFR reporting have resulted in increased identification …

Serum creatinine concentration, the classical biomarker of chronic kidney disease (CKD) in
cats, has important limitations that decrease its value as a biomarker of early CKD. Recently …

Results KIM-1 peaked 2 days after surgery in adults and 1 day after surgery in children,
whereas L-FABP peaked within 6 hours after surgery in both age groups. In multivariable …